These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 29367077)

  • 21. Synthesis and bioevaluation of N-(3,4,5-trimethoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-amines as tubulin polymerization inhibitors with anti-angiogenic effects.
    Hao SY; Qi ZY; Wang S; Wang XR; Chen SW
    Bioorg Med Chem; 2021 Feb; 31():115985. PubMed ID: 33421913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of pyrazolo[3,4-b]pyridines under microwave irradiation in multi-component reactions and their antitumor and antimicrobial activities - Part 1.
    El-borai MA; Rizk HF; Abd-Aal MF; El-Deeb IY
    Eur J Med Chem; 2012 Feb; 48():92-6. PubMed ID: 22178093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel alkyl amide functionalized trifluoromethyl substituted pyrazolo[3,4-b]pyridine derivatives as potential anticancer agents.
    Chavva K; Pillalamarri S; Banda V; Gautham S; Gaddamedi J; Yedla P; Kumar CG; Banda N
    Bioorg Med Chem Lett; 2013 Nov; 23(21):5893-5. PubMed ID: 24060486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel trifluoromethyl substituted furo[2,3-b]pyridine and pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as potential anticancer agents.
    Naresh Kumar R; Poornachandra Y; Nagender P; Mallareddy G; Ravi Kumar N; Ranjithreddy P; Ganesh Kumar C; Narsaiah B
    Eur J Med Chem; 2016 Jan; 108():68-78. PubMed ID: 26629861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, Cytotoxicity, Antimicrobial and Docking Simulation of Novel Pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[3,4-c] pyrimidine Derivatives.
    Hassaneen HM; Saleh FM; Abdallah TA; Mohamed MF; Mohamed YS; Awad EM; Abdelhamid IA
    Mini Rev Med Chem; 2019; 19(8):657-670. PubMed ID: 30332953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4-b]pyridines with potential p38α MAPK-inhibitory activity.
    Farahat AA; Samir EM; Zaki MY; Serya RAT; Abdel-Aziz HA
    Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100302. PubMed ID: 34796536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Facile synthesis and in-vitro antitumor activity of some pyrazolo[3,4-b]pyridines and pyrazolo[1,5-a]pyrimidines linked to a thiazolo[3,2-a]benzimidazole moiety.
    Abdel-Aziz HA; Saleh TS; El-Zahabi HS
    Arch Pharm (Weinheim); 2010 Jan; 343(1):24-30. PubMed ID: 19921685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiproliferative activity in vitro of new 2-, 3- or 4-substituted pyrido[2',3':3,4]pyrazolo[1, 5-a]pyrimidines.
    Poreba K; Wietrzyk J; Opolski A
    Acta Pol Pharm; 2006; 63(3):189-94. PubMed ID: 20085223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of novel 1,2,3-triazole tagged pyrazolo[3,4-b]pyridine derivatives and their cytotoxic activity.
    Kurumurthy C; Veeraswamy B; Sambasiva Rao P; Santhosh Kumar G; Shanthan Rao P; Loka Reddy V; Venkateswara Rao J; Narsaiah B
    Bioorg Med Chem Lett; 2014 Feb; 24(3):746-9. PubMed ID: 24424132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationships of pyrazolo-[3,4-b]pyridine derivatives as adenosine 5'-monophosphate-activated protein kinase activators.
    Zheng B; Peng Y; Wu W; Ma J; Zhang Y; Guo Y; Sun S; Chen Z; Li Q; Hu G
    Arch Pharm (Weinheim); 2019 Aug; 352(8):e1900066. PubMed ID: 31373047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of novel hydrazone and azole functionalized pyrazolo[3,4-b]pyridine derivatives as promising anticancer agents.
    Nagender P; Naresh Kumar R; Malla Reddy G; Krishna Swaroop D; Poornachandra Y; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4427-4432. PubMed ID: 27528432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel pyrazolo[3,4-b]pyridine scaffold-based derivatives as potential PIM-1 kinase inhibitors in breast cancer MCF-7 cells.
    Nafie MS; Amer AM; Mohamed AK; Tantawy ES
    Bioorg Med Chem; 2020 Dec; 28(24):115828. PubMed ID: 33166925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of novel ethyl 2,4-disubstituted 8-(trifluoromethyl)pyrido[2',3':3,4]pyrazolo[1,5-a]pyrimidine-9-carboxylate derivatives as promising anticancer agents.
    Ravi Kumar N; Poornachandra Y; Krishna Swaroop D; Jitender Dev G; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5203-5206. PubMed ID: 27720296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.
    Samala G; Devi PB; Nallangi R; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013 Nov; 69():356-64. PubMed ID: 24077526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
    Yuan L; Song C; Li C; Li Y; Dong L; Yin S
    Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological evaluation of 1H-pyrrolo[2,3-b]pyridine and 1H-pyrazolo[3,4-b]pyridine derivatives as c-Met inhibitors.
    Liu N; Wang Y; Huang G; Ji C; Fan W; Li H; Cheng Y; Tian H
    Bioorg Chem; 2016 Apr; 65():146-58. PubMed ID: 26950400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, antimicrobial, antiquorum-sensing and antitumor evaluation of new series of pyrazolopyridine derivatives.
    El-Gohary NS; Shaaban MI
    Eur J Med Chem; 2018 Sep; 157():729-742. PubMed ID: 30138804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Approaches for the Synthesis of Fused Thiophene, Pyrazole, Pyran and Pyridine Derivatives with Anti-Proliferative Together with c-Met Kinase and Prostate Cancer Cell Inhibitions.
    Mohareb RM; Milad YR; El-Ansary RA
    Anticancer Agents Med Chem; 2021; 21(13):1751-1766. PubMed ID: 33176664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticancer profile and anti-inflammatory effect of new N-(2-((4-(1,3-diphenyl-1H-pyrazol-4-yl)pyridine sulfonamide derivatives.
    Abdel-Maksoud MS; Mohamed Hassan R; Abdel-Sattar El-Azzouny A; Nabil Aboul-Enein M; Oh CH
    Bioorg Chem; 2021 Dec; 117():105424. PubMed ID: 34678604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation, and docking studies of new pyrazole-based thiourea and sulfonamide derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    Ullah S; El-Gamal MI; Zaib S; Anbar HS; Zaraei SO; Sbenati RM; Pelletier J; Sévigny J; Oh CH; Iqbal J
    Bioorg Chem; 2020 Jun; 99():103783. PubMed ID: 32224334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.